| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c718ada04b08ffc251ea5c07da78fbc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-515 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12H1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-00 |
| filingDate |
2000-12-15^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-12-04^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecc7b3e14a26eaa552d6a0ce5b16e605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea86e3e179ee409d332eecf92a55e0bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_444a8cf4f725ff11e052abda8d09bf37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faf1df12684edcdef8411f90a1d53ad5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7b7fc8a0369671ec2fc275fb2487cef |
| publicationDate |
2007-12-04^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7304151-B2 |
| titleOfInvention |
Modified leukotoxin gene and protein |
| abstract |
The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica . The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7932085-B2 |
| priorityDate |
1999-12-17^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |